Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVX
2626
DELISTED
AVX Corporation
AVX
| $494K | ﹤0.01% |
36,705
-73,464
| -67% | -$1.04M |
|
|
TYPE
2627
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $494K | ﹤0.01% |
20,507
+10,300
| +101% | +$290K |
|
|
PGTI
2628
DELISTED
PGT, Inc.
PGTI
| $492K | ﹤0.01% |
33,900
-86,876
| -72% | -$1.08M |
|
|
EGOV
2629
DELISTED
NIC Inc
EGOV
| $492K | ﹤0.01% |
26,936
-134,187
| -83% | -$2.34M |
|
|
BPY
2630
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $491K | ﹤0.01% |
22,288
| – | – |
|
|
WW
2631
PUT
DELISTED
WW International
WW
| $485K | ﹤0.01% |
100,000
| – | – |
|
|
ATRS
2632
CALL
DELISTED
Antares Pharma, Inc.
ATRS
| $485K | ﹤0.01% |
+233,300
| New | +$566K |
|
|
DRD
2633
DRDGold
DRD
$2.6B
| $484K | ﹤0.01% |
261,444
-24,056
| -8% | -$43.2K |
|
|
AFOP
2634
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
| $483K | ﹤0.01% |
+26,021
| New | +$499K |
|
2635
Omeros
OMER
$1.34B
| $482K | ﹤0.01% |
+26,778
| New | +$578K |
|
|
TSYS
2636
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $481K | ﹤0.01% |
145,264
-6,414
| -4% | -$21.6K |
|
|
OLBK
2637
DELISTED
Old Line Bancshares, Inc.
OLBK
| $480K | ﹤0.01% |
+30,230
| New | +$482K |
|
2638
Lifecore Biomedical
LFCR
$175M
| $479K | ﹤0.01% |
+33,223
| New | +$479K |
|
|
LOCK
2639
DELISTED
LifeLock, Inc.
LOCK
| $479K | ﹤0.01% |
29,202
-610,449
| -95% | -$9.44M |
|
2640
RLI Corp
RLI
$6B
| $478K | ﹤0.01% |
+18,610
| New | +$469K |
|
2641
RE/MAX Holdings
RMAX
| $476K | ﹤0.01% |
13,402
+3,628
| +37% | +$123K |
|
2642
Miller Industries
MLR
$642M
| $475K | ﹤0.01% |
+23,813
| New | +$523K |
|
|
PDM
2643
Piedmont Realty Trust
PDM
$1.24B
| $475K | ﹤0.01% |
27,000
-423,709
| -94% | -$7.53M |
|
2644
Urban One Class D
UONEK
$20.8M
| $475K | ﹤0.01% |
14,976
+13,550
| +950% | +$494K |
|
|
RPT
2645
Rithm Property Trust
RPT
$102M
| $474K | ﹤0.01% |
5,762
-311
| -5% | -$25.3K |
|
|
OIBR
2646
DELISTED
OI S A SPONSORED ADR REPSTG PFD NEW (BRA)
OIBR
| $472K | ﹤0.01% |
247,360
-218,971
| -47% | -$444K |
|
2647
Noodles & Co
NDLS
$90.8M
| $471K | ﹤0.01% |
4,035
-9,519
| -70% | -$1.29M |
|
2648
Interparfums
IPAR
$3.74B
| $468K | ﹤0.01% |
13,788
-2,824
| -17% | -$93.5K |
|
2649
NewtekOne
NEWT
$361M
| $466K | ﹤0.01% |
26,300
+14,614
| +125% | +$257K |
|
|
SHLO
2650
DELISTED
Shiloh Industries Inc
SHLO
| $466K | ﹤0.01% |
35,978
+22,552
| +168% | +$276K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.